Skip to main content

HUMALOG insulin lispro 100 IU/mL injection multidose cartridge, Eli Lilly Australia Pty Ltd, CON-1219

Product name
HUMALOG insulin lispro 100 IU/mL injection multidose cartridge
Sponsor name
Eli Lilly Australia Pty Ltd
Consent start
Consent no.
CON-1219
Duration
The consent is effective from 22 March 2024 until 31 March 2025.
Standard
paragraph 8 (1)(i) of Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines
Non-compliance with standard
The product labels do not include the current address for the sponsor, and say North Ryde, NSW in place of Sydney, NSW
Import, Supply, &/or Export
import and supply
Therapeutic product type
Prescription medicines

Help us improve the Therapeutic Goods Administration site